eth.limo gateway suffered a domain hijacking via social engineering attack on EasyDNS. DNSSEC prevented damage in the registrar’s first breach in 28 years.
Author: Trader Edge
Read More
Ethereum vs Solana 2026: Analyzing market cap, upgrades, DEX data, and institutional adoption to determine which crypto offers better value today.
RaveDAO (RAVE) token plummeted 95% from $28.90 to $1.24 amid manipulation allegations, insider wallet claims, and investigations by major exchanges.
KelpDAO’s $293M bridge exploit triggered a $13B DeFi crash in 48 hours, leaving Aave with $195M bad debt and over $5B in frozen stablecoin reserves.
Polymarket pursues $400M funding at $15B valuation. ICE invested $600M, with total round potentially hitting $1B amid regulatory scrutiny.
Vercel confirmed a breach via Context.ai that exposed customer data. Crypto projects hosted on the platform are rotating keys as hackers demand $2M ransom.
Asteroid Shiba (ASTEROID) surged 920% after Elon Musk agreed to make a Shiba Inu plush the SpaceX mascot. One trader missed out on $2.6M in gains.
XRP holds steady at $1.40 with volatility at multi-year lows and $1.27B in inflows. Analysts identify triangle pattern signaling potential 35% move.
Bitcoin dips just 1.6% as U.S.-Iran tensions push oil up 5.7% and stock futures down. See how markets reacted to the weekend’s naval seizure.
Ethereum drops 8% to $2,253 amid US-Iran tensions. ETF inflows hit $276M while 32% of supply staked. Key support and resistance levels analyzed.
Wrapped XRP launches on Solana as ETF holdings reach $1.08B. A $292M KelpDAO exploit raises questions about cross-chain security for wXRP users.
Kelp DAO lost $290M in a hack linked to Lazarus Group. LayerZero blames single-verifier setup, affecting Aave and 8 other DeFi protocols.
Bitcoin fell to $73,753 after Iran rejected U.S. peace talks, erasing weekend gains. Ceasefire expires April 22 amid rising Middle East tensions.
Analysis of 5 top dividend stocks: AbbVie, Chevron, Shell, Enterprise Products Partners & Realty Income. Strong yields backed by solid fundamentals.
Definium Therapeutics (DFTX) stock rises after supporting White House psychedelic treatment order. Stifel initiates with $30 Buy rating.